25.01.2025
... -1,18%, Merck Co. -2,42%, Ibu-Tec -2,76%, Epigenomics -6,99%, Paion ... Merck Co. -3,92% , Paion -5,2% , Ibu-Tec -7,04% , Epigenomics -8,58% , Medigene - ...
18.01.2025
... 2,82%, Sanofi 2,7%, Amgen 1,98%, Ibu-Tec 1,24%, Linde 0,05%, MorphoSys 0%, ... % , Epigenomics -8,58% , Evotec -9,97% , Ibu-Tec -12,37% , Medigene -12,88 ...
11.01.2025
... -8,58% , Medigene -12,88% , Ibu-Tec -12,97% , GlaxoSmithKline -14,1% , Lanxess ... (Vorjahr: -17,2 Prozent) und Ibu-Tec -3,59% (Vorjahr: -63,01 ...
04.01.2025
... BASF -2,77%, Sartorius -3,21%, Ibu-Tec -4,49%, Epigenomics -6,99%, Paion ... 12,88% , GlaxoSmithKline -14,1% , Ibu-Tec -26,16% , Weitere Highlights: Baxter ...
04.01.2025
... Boss BOSS 42.58 -3.56% Ibu-Tec IBU 6.38 -3.63% BayWa BYW6 11 ...
28.12.2024
... -0,28%, Baxter International -1,02%, Ibu-Tec -1,47%, Epigenomics -6,99%, Paion ... % , Valneva mit +2,71% , Ibu-Tec mit +1,05% , Baxter International mit ...
21.12.2024
... 67% , Novartis -4,77% , Paion -5,2% , Ibu-Tec -5,83% , Bayer -6,05% , Amgen -6,3% ... focus.de/magazin/archiv/ibu-tec-wette-auf-grossauftrag_id_221472673. ...